A critical breakthrough in cancer study is emerging with the use of mini-antibodies to reactivate damaged p53. This crucial tumor protector protein is frequently lost in many types of malignancies, causing uncontrolled https://socialmediatotal.com/story7027448/mini-antibodies-reactivate-p53-the-promising-pathway-for-malignant-management